Clinical Trial Update: A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial to evaluate Fitusiran for preventing bleeds in people with severe Hemophilia A who previously received Emicizumab; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Fitusiran (fitusiran)

Snippet

Sponsor: Sanofi | Conditions: Hemophilia A | Phase 4 | Status: RECRUITING